Use of <scp>F</scp>actor <scp>XIII</scp> (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures

Abstract

Preoperative plasma-derived FXIII concentrate allowed for sufficient hemostasis in most patients with FXIII deficiencies. Additional doses were necessary to achieve hemostasis in one patient who underwent a CPB procedure.